Compare AGX & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGX | HAE |
|---|---|---|
| Founded | 1961 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | N/A | 1991 |
| Metric | AGX | HAE |
|---|---|---|
| Price | $315.82 | $79.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $321.00 | $84.38 |
| AVG Volume (30 Days) | 451.3K | ★ 854.6K |
| Earning Date | 12-04-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.63% | N/A |
| EPS Growth | ★ 76.74 | 42.54 |
| EPS | ★ 8.49 | 3.44 |
| Revenue | $915,030,000.00 | ★ $1,327,850,000.00 |
| Revenue This Year | $11.43 | N/A |
| Revenue Next Year | $18.27 | $6.01 |
| P/E Ratio | $37.66 | ★ $24.30 |
| Revenue Growth | ★ 13.49 | N/A |
| 52 Week Low | $101.02 | $47.32 |
| 52 Week High | $399.30 | $87.32 |
| Indicator | AGX | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 60.16 |
| Support Level | $307.64 | $82.30 |
| Resistance Level | $341.00 | $87.32 |
| Average True Range (ATR) | 19.84 | 2.21 |
| MACD | -6.82 | -0.91 |
| Stochastic Oscillator | 33.89 | 19.56 |
Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.